Skip to content
EyeWorld Logo
  • ASCRS News
  • Cataract
  • Refractive
  • Cornea
  • Glaucoma
  • Practice Management
  • Non-CME Programs & Projects
    • Corporate Replay
    • Corporate Educational Events
    • Supplements
Menu Close
  • ASCRS News
  • Cataract
  • Refractive
  • Cornea
  • Glaucoma
  • Practice Management
  • Non-CME Programs & Projects
    • Corporate Replay
    • Corporate Educational Events
    • Supplements

Contact

Contact us

Have questions or comments? Send us a message.

    Name

    Email

    Subject

    Your Message

    EyeWorld Weekly

    February 12, 2021
    1. NDA filed for topical glaucoma and ocular hypertension ophthalmic solution
    2. Nepafenac vs. placebo, results from Phase 2 study
    3. Enrollment completed for photobiomodulation treatment trial
    4. ASCRS activity updates

    Read EW Weekly Archives

    Archives

    • EyeWorld
    • Supplements
    • EyeWorld Daily News
    • EyeWorld Weekly

    EyeWorld

    • About
    • Contact
    • ASCRS.org
    • ASCRSmedia
    © 2021 EyeWorld News Service. All rights reserved. Legal Notice
    We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.